Konica Minolta, DiA add echo AI analysis of COVID-19

2020 02 19 17 31 0316 Konica Minolta Rsna 2019 400

Konica Minolta Healthcare Americas and DiA Imaging Analysis have expanded their partnership to support artificial intelligence (AI) analysis of echocardiography studies in patients with COVID-19.

The two companies had initially agreed to add DiA's LVivo Toolbox to Konica Minolta's Exa Cardio PACS in a partnership announced in July 2019. With the new capabilities, Exa users can perform automated quantitative analysis of the left ventricle to detect cardiac dysfunction in COVID-19 cases.

When used with Konica Minolta's zero-footprint Exa Universal Viewer and reporting system, the LVivo EF software can be utilized on any workstation to monitor the global heart function of patients with COVID-19, according to the vendors.

In other developments, Konica Minolta and DiA noted that Exa users can now perform myocardial strain imaging using DiA's LVivo Strain application and submit for reimbursement.

Page 1 of 512
Next Page